HDAC9 and non-Hodgkin lymphoma: Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur <i>in vitro</i> and <i>in vivo</i> and proceed through multiple mechanisms.